|
|
Volumn 16, Issue 5S, 2018, Pages 620-623
|
|
NCCN guidelines updates: Prostate cancer and prostate cancer early detection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
ANDROGEN DEPRIVATION THERAPY;
CONFERENCE PAPER;
DISEASE SURVEILLANCE;
EARLY CANCER DIAGNOSIS;
HUMAN;
MOLECULAR GENETICS;
PRACTICE GUIDELINE;
PROSTATE BIOPSY;
PROSTATE CANCER;
SHARED DECISION MAKING;
AGE;
BLOOD;
CANCER STAGING;
DECISION MAKING;
DIAGNOSTIC IMAGING;
GENETIC SCREENING;
LARGE CORE NEEDLE BIOPSY;
MALE;
MASS SCREENING;
MEDICAL SOCIETY;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ONCOLOGY;
PATHOLOGY;
PATIENT SELECTION;
PROCEDURES;
PROSTATE;
PROSTATE TUMOR;
RISK ASSESSMENT;
UNITED STATES;
URINE;
UROLOGY;
WATCHFUL WAITING;
AGE FACTORS;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOMARKERS, TUMOR;
BIOPSY, LARGE-CORE NEEDLE;
DECISION MAKING;
EARLY DETECTION OF CANCER;
GENETIC TESTING;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MASS SCREENING;
MEDICAL ONCOLOGY;
MIDDLE AGED;
NEOPLASM STAGING;
PATIENT SELECTION;
PROSTATE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
SOCIETIES, MEDICAL;
UNITED STATES;
UROLOGY;
WATCHFUL WAITING;
|
|
EID: 85048257226
PISSN: 15401405
EISSN: 15401413
Source Type: Journal
DOI: 10.6004/jnccn.2018.0036 Document Type: Conference Paper |
|
Times cited : (250)
|
|
References (4)
|
